1.
Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic
by Detoc, Maëlle
Vaccine, 2020-10-21, Vol.38 (45), p.7002-7006
2.
3.
Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide
by Muzzi, Alessandro
Vaccine, 2019-02-08, Vol.37 (7), p.991-1000
4.
The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004–2014
by Whittaker, Robert
Vaccine, 2017, Vol.35 (16), p.2034-2041
5.
Why France is making eight new vaccines mandatory
by Ward, Jeremy K
Vaccine, 2018-03-27, Vol.36 (14), p.1801-1803
6.
Freeze-drying of live virus vaccines: A review
by Hansen, L.J.J
Vaccine, 2015, Vol.33 (42), p.5507-5519
7.
Amphiphilic block copolymer delivery of a DNA vaccine against Zika virus
by Hraber, Peter
Vaccine, 2018-11-12, Vol.36 (46), p.6911-6917
8.
Social differentiation of vaccine hesitancy among French parents and the mediating role of trust and commitment to health: A nationwide cross-sectional study
by Bocquier, Aurélie
Vaccine, 2018-11-29, Vol.36 (50), p.7666-7673
9.
Playing vaccine roulette: Why the current strategy of staking everything on Covid-19 vaccines is a high-stakes wager
by Paul, Elisabeth
Vaccine, 2021-08-16, Vol.39 (35), p.4921-4924
10.
Targeting a global health problem: Vaccine design and challenges for the control of tick-borne diseases
by de la Fuente, José
Vaccine, 2017-09-12, Vol.35 (38), p.5089-5094
11.
COVID-19 vaccine hesitancy among persons living in homeless shelters in France
by Longchamps, C
Vaccine, 2021-06-08, Vol.39 (25), p.3315-3318
12.
Vaccine hesitancy and self-vaccination behaviors among nurses in southeastern France
by Wilson, Rose
Vaccine, 2020-01-29, Vol.38 (5), p.1144-1151
13.
A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years:...
by Fadlyana, Eddy
Vaccine, 2021-10-22, Vol.39 (44), p.6520-6528
14.
Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world’s most vaccine-hesitant countries
by Cambon, L
Vaccine, 2022-01-21, Vol.40 (2), p.178-182
15.
Human papillomavirus vaccination coverage, policies, and practical implementation across Europe
by Nguyen-Huu, Ngoc-Ha
Vaccine, 2020-02-05, Vol.38 (6), p.1315-1331
16.
Barriers and motivations for participation in preventive vaccine clinical trials: Experience of 5 clinical research sites
by Detoc, M
Vaccine, 2019-10-16, Vol.37 (44), p.6633-6639
17.
The WHO position on rabies immunization – 2018 updates
by O'Brien, Katherine L
Vaccine, 2019-10-03, Vol.37, p.A85-A87
18.
A combined measure of tuberculous lesions for assessing the efficacy of vaccination against tuberculosis (Mycobacterium bovis) in European badgers (Meles meles) supports the 3Rs pr...
by Birch, Colin P.D
Vaccine, 2021-03-12, Vol.39 (11), p.1661-1666
19.
The role of maturity in adolescent decision-making around HPV vaccination in France
by Karafillakis, E
Vaccine, 2021-09-24, Vol.39 (40), p.5741-5747
20.
Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?
by Hong, Eva
Vaccine, 2012, Vol.31 (7), p.1113-1116
Filter electronic articles 21.978 Hits
Remove Filters
- Journal Title
- Vaccine
- Vaccine 23: 4342-4352 (1)
- Vaccine 26: 4494-4505 (1)
- more ...
- Subjects
- Immunology (21.978)
- Research & Experimental Medicine
- Science & Technology (21.978)
- more ...